All data are based on the daily closing price as of September 9, 2025
j

JW Pharmaceutical

001060.KO
16.27 USD
0.08
+0.49%

Overview

Last close
16.27 usd
Market cap
370.61M usd
52 week high
24.65 usd
52 week low
13.57 usd
Target price
24.54 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.6898
Price/Book Value
1.6197
Enterprise Value
394.60M usd
EV/Revenue
0.7361
EV/EBITDA
4.5446

Key financials

Revenue TTM
536.09M usd
Gross Profit TTM
248.39M usd
EBITDA TTM
79.81M usd
Earnings per Share
N/A usd
Dividend
0.32 usd
Total assets
436.00M usd
Net debt
N/A usd

About

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
  • Symbol
    001060.KO
  • Exchange
    KO
  • Isin
    KR7001060003
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Sub Shin
  • Headquarter
    Gwacheon-si
  • Web site
    https://www.jw-pharma.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top